GBB was awarded the Top 50 Innovative Biotechnology Companies

Created on:2020-12-29 11:22

logo

December 29th,2020 Press Release

 

GBB was awarded the Top 50 Innovative Biotechnology Companies

 

[2020/12/3, Dongguan]On December 23, 2020, the 3rd Guangdong-Hong Kong-Macao-Greater Bay Area Biotechnology Innovation Enterprise Top 50 Competition, which lasted for nearly half a year, was successfully concluded, and Great Bay Bio was awarded as the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Area and the title of "Pioneer Enterprise".

Organized by ZDVC RESEARCH and KPMG China and hosted by Guangdong Medical Valley, the event aims to discover the future unicorns of biotechnology in the Greater Bay Area and give a boost to the overall biotechnology industry in this area. Great Bay Bio has pioneered the application of artificial intelligence biotechnology in several R&D steps of biopharmaceuticals, and was successfully selected as one of the top 50 biotech innovation enterprises in Guangdong, Hong Kong and Macau, and awarded the title of "Pioneer Enterprise".

Dr. Sean Deng, Director of Intelligent Biologics of Great Bay Bio, said, "the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Award has greatly promoted the cooperation among the three regions and the development of biotechnology innovation in the Greater Bay Area. In the future, Great Bay Bio will continue to take innovation-driven R&D as its core competitiveness to empower biopharmaceutical development and make biopharmaceutical development easier and more efficient.

 

About the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Area

Since June 2018, the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macau Greater Bay Area Award has been successfully held for three times, which comprehensively evaluates the technological innovation degree and future development prospects of the participating enterprises from three dimensions: leading technology application and breakthrough, commercially availability, valuation and capital market recognition. In recent years, high-quality enterprises in Guangdong, Hong Kong and Macao Greater Bay Area have been highly sought after by the capital market, thus led to strong demand for financing, and the Top 50 enterprises have been performing remarkably, gradually developing into the backbone of the biotechnology industry in the Greater Bay Area.

 

About Great Bay Bio

Headquartered in Hong Kong, GBB is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to CMC (Chemistry, Manufacturing, Control) for development of biopharmaceuticals and other blue ocean bio-products (such as cell therapy), ultimately solving numerous pain points of CMC development, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has obtained massive data from conventional biologics development in its 3100 m2 CMC facilities in Dongguan, PRC. With over RMB 300M investment, the facilities bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created the intelligent centralized database, where deep learning is being performed to create next generation AI-enabled CMC platforms. To learn more, please visit http://www.greatbay-bio.com.

 

PR Contact: Miss Liu 

Email: yt.liu@greatbay-bio.co

Home    News    GBB was awarded the Top 50 Innovative Biotechnology Companies
PV:0
Collect